Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of gastric microbiota eradication therapy for gastric intestinal metaplasia
jRCTs031260486Recruiting
- Sponsor
- Yokohama City University
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of vonoprazan, metronidazole and sitafloxacin in Intestinal metaplasia (2 arms), sponsored by Yokohama City University. Primary endpoint: Improvement rate of histological intestinal metaplasia. Started Sep 2026; status: recruiting.
02
Drugs
vonoprazanmetronidazolesitafloxacin
03
Conditions
Intestinal metaplasia
Beyond the preview
Go deeper on jRCTs031260486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031260486.